Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

'Speaking Out' on Legal Protection in Cancer

December 19th 2019, 7:00pm

Podcast

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lisa Schlager, from FORCE, about the types of legal protections in place for those with a genetic risk for cancer.

How Genetic Testing Saved One Woman's Life

December 6th 2019, 7:00pm

Article

Two-time cancer survivor Anne Weber feels fortunate to have learned of her BRCA2 gene mutation, as it led to an early diagnosis of aggressive breast cancer.

CURE's Clinical Trial Corner: November 2019

November 30th 2019, 12:00am

Article

Here is a list of the recent trial initiations that occurred within the cancer space in November.

Friday Frontline: Cancer Updates, Research and Education on November 29, 2019

November 29th 2019, 7:00pm

Article

From the first patient death under the Right to Try law to a 9-year-old ovarian cancer survivor meeting her hero Jim Cantore, here’s what is making headlines in the cancer space this week.

Dealing With a Second Relapse

November 26th 2019, 10:00pm

Article

“When learning about a second relapse, the only thing I could think was, ‘Oh no. Not again. This cannot be happening.”

When Cancer Comes Back

November 18th 2019, 10:00pm

Article

You never expect to get a diagnosis of cancer, but what about when it comes back?

New Guidelines Call for Gene Screening for Cancer Survivors

November 8th 2019, 3:00am

Article

Revised federal guidelines recommend that more women, especially cancer survivors, be considered for genetic screening for hereditary breast and ovarian cancer.

Counting the Days of Chemotherapy

November 6th 2019, 10:00pm

Article

I was never any good at math, but I can count. So I learned to live by this bit of information by counting the days that passed after my treatments for ovarian cancer.

What You Need to Know About the FDA's Approval of Zejula

November 1st 2019, 1:00am

Article

The Food and Drug Administration’s recent approval of Zejula for certain patients with advanced ovarian, fallopian tube or primary peritoneal cancer was the first PARP inhibitor approved for the treatment, not the maintenance, of these women.

Day One is Always Memorable in the Saga of Chemotherapy

October 30th 2019, 8:00pm

Article

Looking back on Day One in the chemotherapy journey.